Next |
home / stock / nvcr / nvcr message board
Subject | By | Source | When |
---|---|---|---|
You go to $NWBO MB and thumsy up | KIPK | investorshub | 04/28/2023 3:58:51 PM |
LOL - THI HAT HAS NO CHNCE. THE | KIPK | investorshub | 04/28/2023 1:02:50 PM |
$NVCR has a great chance of retaking the | whosleftholdindabag | investorshub | 04/27/2023 9:21:22 PM |
Won't make a diff. SP will continue to | KIPK | investorshub | 04/27/2023 12:44:45 PM |
Results of LUNAR at ASCO. Also, nine other | jondoeuk | investorshub | 04/26/2023 6:00:33 PM |
LOL - Sounds like Jonk to me | KIPK | investorshub | 04/21/2023 12:16:28 PM |
LOL - NoCure has no future - Just | KIPK | investorshub | 04/21/2023 12:15:07 PM |
Crash, $NVCR has a MUCH brighter future than | whosleftholdindabag | investorshub | 04/20/2023 10:42:10 PM |
The PR https://www.businesswire.com/news/home/20230413005882/en/Novocure-Announc | jondoeuk | investorshub | 04/14/2023 8:26:19 PM |
As someone once said, ''Never argue with an | jondoeuk | investorshub | 04/13/2023 10:07:17 PM |
Novocure has no product that works. | CrashOverride | investorshub | 04/13/2023 3:52:21 PM |
Rarely do I capitalize on buying at the | whosleftholdindabag | investorshub | 04/13/2023 12:15:18 PM |
Opinion (bad one) And for someone who is always | Legend431 | investorshub | 03/28/2023 1:57:48 PM |
Optune, junk science! | CrashOverride | investorshub | 03/28/2023 3:53:06 AM |
Can you believe this 18 months ago was | Zadie420 | investorshub | 03/19/2023 4:32:01 PM |
You missing the fact that the tinfoil is | KIPK | investorshub | 03/19/2023 1:52:28 PM |
Quoting AACR the only one to publish Adam | The Danish Dude | investorshub | 03/19/2023 10:54:08 AM |
Also, | jondoeuk | investorshub | 03/18/2023 3:49:51 AM |
AACR abstracts (the event is next month). | jondoeuk | investorshub | 03/18/2023 3:19:48 AM |
Simply put, no. | jondoeuk | investorshub | 03/17/2023 11:46:11 PM |
News, Short Squeeze, Breakout and More Instantly...
NovoCure Limited Company Name:
NVCR Stock Symbol:
NASDAQ Market:
2024-05-03 01:00:11 ET Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q1 2024 Earnings Call May 02, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: NovoCure (NVCR) Q1 2024 Earnings Call Transcript
Use of proceeds to fund working capital needs stemming from Novocure’s anticipated launch in non-small cell lung cancer and settle, upon maturity, Novocure’s convertible notes Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 milli...